Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.58 |
| ▸ | NOS1 | P29475 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.48 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.48 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.48 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.48 |
| ▸ | HTR3B | O95264 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.48 |
| ▸ | HTR3A | P46098 | 1/20 | 0.48 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.48 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8155649 | 1.00 | NOS3 (0.58) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL1890792 | 1.00 | NOS3 (0.58) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL15073401 | 0.95 | NOS3 (0.52) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL15073411 | 0.89 | NOS1 (0.56) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL16382908 | 0.87 | CYP2D6 (0.53) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL11421052 | 0.87 | CYP2D6 (0.53) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL11421050 | 0.87 | CYP2D6 (0.53) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL9302496 | 0.87 | ESR1 (0.53) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL22594341 | 0.87 | CYP2D6 (0.63) | NOS3NOS1MEN1KMT2ALMNA | |
| SCHEMBL15073407 | 0.85 | LMNA (0.49) | NOS3NOS1MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0036312-B1 | PROCESS FOR PRODUCING P-NITROANILINE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-09-28 | — | — | EP | claimed |
| US-4370502-A | NITRATION OF AN ALPHA-METHYLBENZALANILINE USING NITRIC ACID, ANALIPHATIC HALOGEN SOLVENT AND SULFURIC ACID; HYDROLYSIS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1983-01-25 | — | — | US | claimed |
| EP-0036312-A2 | Process for producing p-nitroaniline | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1981-09-23 | — | — | EP | claimed |
| WO-2024100405-A1 | CATALYTIC HYDROGENATION PROCESS | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2024-05-16 | — | — | WO | disclosed |
| EP-3227018-B1 | CHELATION DIRECTED C-H ACTIVATION REACTIONS CATALYZED BY SOLID-SUPPORTED PALLADIUM(II) CATALYSTS | UNIV VIRGINIA COMMONWEALTH (US) | 2021-06-30 | — | — | EP | disclosed |
| WO-2020221834-A1 | PHOSPHAZENYL PHOSPHINES, METAL COMPLEXES OF PHOSPHAZENYL PHOSPHINES AND THEIR MANUFACTURING AND USAGE | PHILIPPS-UNIVERSITÄT MARBURG (DE) | 2020-11-05 | — | — | WO | disclosed |
| US-10385084-B2 | Iron(II) catalysts containing tridentate PNP ligands, their synthesis, and use thereof | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2019-08-20 | — | — | US | disclosed |
| US-10000453-B2 | Chelation directed C—H activation reactions catalyzed by solid-supported palladium(II) catalysts | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2018-06-19 | — | — | US | disclosed |
| US-20170362181-A1 | CHELATION DIRECTED C-H ACTIVATION REACTIONS CATALYZED BY SOLID-SUPPORTED PALLADIUM(II) CATALYSTS | VIRGINIA COMMONWEALTH UNIVERSITY | 2017-12-21 | — | — | US | disclosed |
| EP-3227018-A1 | CHELATION DIRECTED C-H ACTIVATION REACTIONS CATALYZED BY SOLID-SUPPORTED PALLADIUM(II) CATALYSTS | Virginia Commonwealth University (US) | 2017-10-11 | — | — | EP | disclosed |
| US-20160326202-A1 | IRON(II) CATALYSTS CONTAINING TRIDENTATE PNP LIGANDS, THEIR SYNTHESIS, AND USE THEREOF | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-11-10 | — | — | US | disclosed |
| EP-1086941-A1 | PROCESS FOR PREPARING REDUCTANTS OF UNSATURATED ORGANIC COMPOUNDS BY THE USE OF TRICHLOROSILANE AND REDUCING AGENTS | TOKUYAMA CORPORATION (JP) | 2001-03-28 | — | — | EP | disclosed |
| WO-2001014299-A1 | CHIRAL LIGANDS, TRANSITION-METAL COMPLEXES THEREOF AND USES THEREOF IN ASYMMETRIC REACTIONS | THE PENN STATE RESEARCH FOUNDATION (US) | 2001-03-01 | — | — | WO | disclosed |
| WO-2000014096-A1 | FERROCENE-BASED DIPHOSPHONITES FOR ASYMMETRICAL CATALYSIS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2000-03-16 | — | — | WO | disclosed |
| EP-0947561-A1 | ORGANOPOLYSILOXANE COMPOSITION | THREE BOND CO., LTD. (JP) | 1999-10-06 | — | — | EP | disclosed |
| EP-0036312-B1 | PROCESS FOR PRODUCING P-NITROANILINE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-09-28 | — | — | EP | disclosed |
| US-4370502-A | NITRATION OF AN ALPHA-METHYLBENZALANILINE USING NITRIC ACID, ANALIPHATIC HALOGEN SOLVENT AND SULFURIC ACID; HYDROLYSIS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| US-4370502-A | NITRATION OF AN ALPHA-METHYLBENZALANILINE USING NITRIC ACID, ANALIPHATIC HALOGEN SOLVENT AND SULFURIC ACID; HYDROLYSIS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| EP-0036312-A2 | Process for producing p-nitroaniline | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1981-09-23 | — | — | EP | disclosed |
| EP-0036312-A2 | Process for producing p-nitroaniline | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1981-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10385084-B2 | Iron(II) catalysts containing tridentate PNP ligands, their synthesis, and use thereof | PNP, PNPO, FECH | NOS3 2292/4885NOS1 2555/4885MEN1 3826/4885 |
| US-20170362181-A1 | CHELATION DIRECTED C-H ACTIVATION REACTIONS CATALYZED BY SOLID-SUPPORTED PALLADIUM(II) CATALYSTS | WASF2, SCO2, SOD1 | NOS3 3226/4885NOS1 3133/4885MEN1 4070/4885 |
| US-10000453-B2 | Chelation directed C—H activation reactions catalyzed by solid-supported palladium(II) catalysts | WASF2, SOD1, CD274 | NOS3 3200/4885NOS1 3114/4885MEN1 3985/4885 |
| US-20160326202-A1 | IRON(II) CATALYSTS CONTAINING TRIDENTATE PNP LIGANDS, THEIR SYNTHESIS, AND USE THEREOF | PNP, PNPO, FECH | NOS3 2188/4885NOS1 2578/4885MEN1 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.